![](/img/cover-not-exists.png)
Systemic administration of imiquimod as an adjuvant improves immunogenicity of a tumor-lysate vaccine inducing the rejection of a highly aggressive T-cell lymphoma
Sciullo, Paula Di, Menay, Florencia, Cocozza, Federico, Gravisaco, María José, Waldner, Claudia I., Mongini, ClaudiaLanguage:
english
Journal:
Clinical Immunology
DOI:
10.1016/j.clim.2019.04.013
Date:
April, 2019
File:
PDF, 933 KB
english, 2019